华森制药：已成为健儿消食口服液药品上市许可持有人

Core Viewpoint - Huason Pharmaceutical (002907) has successfully completed the change of drug production license holder for its product Jianer Xiaoshi Oral Liquid, marking a significant regulatory milestone for the company [1] Company Summary - The company announced on September 5 that it received the approval notice from the National Medical Products Administration regarding the supplementary application for the product [1] - The completion of the license holder change indicates that Huason Pharmaceutical is now the legal holder of the drug's marketing authorization [1]